A Clinical Trail of Iodine[131I] Metuximab Injection With CIK Cells for Preventing Hepatocellular Carcinoma
Clinical trial NCT01758679 · UNKNOWN
Trial details
- NCT number
- NCT01758679
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2016-11-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.